Dapirolizumab pegol is an investigational Fc-free polyethylene glycol-conjugated antigen-binding fragment that inhibits CD40 ligand signaling.

Among the novel biological agents for lupus nephritis, renal response within a specific therapeutic time window improves with obinutuzumab, abatacept, and belimumab, investigators report.

Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...

A U.S. judge ruled that Regeneron Pharmaceuticals cannot immediately block U.S. sales of a proposed copy of its blockbuster ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

Ilaris, which treats conditions including Still’s disease, can cause side effects such as unexpected weight gain. Learn about ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

A new study takes a look at a controversial medication recommended by some in the early days of the COVID-19 pandemic. KYW ...

Biogen and UCB said an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal ...